UC joins bipolar research network
Cincinnati Business Courier, Spectrum News highlight $2.3 million grant award
The Cincinnati Business Courier and Spectrum News highlighted the University of Cincinnati receiving a $2.3 million grant to join the Breakthrough Discoveries for Thriving with Bipolar Disorder (BD²) Integrated Network, a collaborative research and clinical care model with a mission to improve care, interventions and outcomes for people living with bipolar disorder.
Working in partnership with clinicians, researchers and people living with bipolar disorder, the BD² Integrated Network was established to expand knowledge of bipolar disorder while accelerating the translation of that knowledge into clinical care. An international site will be announced in the coming weeks.
The BD² Integrated Network is a novel, two-pronged approach connecting bipolar disorder research and care. It combines a traditional longitudinal cohort study of 4,000 participants and a learning health network to iteratively improve outcomes for people with bipolar disorder. Clinical sites have accelerated recruitment, with more than 500 individuals already participating in the study.
UC’s Caleb Adler, MD, will serve as site principal investigator. Patients will be enrolled both at the Lindner Center of Hope and University of Cincinnati Medical Center.
"The BD² Integrated Network is a unique approach to bettering our understanding of bipolar disorder," said Adler, professor, vice chair of research and co-director of the Division of Bipolar Disorders Research in the Department of Psychiatry and Behavioral Neuroscience at UC’s College of Medicine and a UC Health physician. "We are very excited to have the opportunity to contribute to this important effort, a major step toward improving our care for individuals with bipolar disorder."
Read the Cincinnati Business Courier article.
Read the Spectrum News article.
Featured graphic at top of a speech bubble. Photo/bgblue/iStock Photo.
Related Stories
What to know about lung adenocarcinoma following Pope Leo diagnosis
October 14, 2026
The University of Cincinnati Cancer Center's Robert Van Haren, MD, was featured in a Medical News Today article discussing the diagnosis, risk factors, symptoms and treatment of lung adenocarcinoma in light of Pope Leo XIV's recent diagnosis.
UC researchers help demonstrate proof-of-concept gene therapy for hydrocephalus
October 14, 2026
A proof-of-concept study led by UC’s Agnes (Yu) Luo, PhD, and collaborators at UC Davis shows that an adeno-associated virus (AAV) gene therapy can reduce hydrocephalus-associated tissue damage in animal models, pointing to a potential new treatment strategy.
How Ohio's political landscape has changed
October 13, 2026
UC Professor David Niven tells Spectrum News that Ohio has become a Republican stronghold after once serving as a bellwether for national elections.